Characterization of factors associated with systemic corticosteroid use in severe asthma: Data from the Severe Asthma Research Program

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 3, 2014, Pages 915-918

  Wysocki, Kenneth ^a   Park, Seo Young ^a   Bleecker, Eugene ^b   Busse, William ^c   Castro, Mario ^d   Chung, Kian Fan ^e   Gaston, Benjamin ^f   Erzurum, Serpil ^g   Israel, Elliot ^h   Teague, W Gerald ⁱ   Moore, Charity G ^a   Wenzel, Sally ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AIRWAY OBSTRUCTION; ASTHMA; BODY MASS; BRONCHITIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; LUNG FUNCTION; MEDICAL HISTORY; NEUTROPHIL; NEUTROPHIL COUNT; OBESITY; OSTEOPOROSIS; PASSIVE SMOKING; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; RISK FACTOR; SINUSITIS; SMOKING;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84896725213     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.10.031     Document Type: Article

References (9)

1. K.F. Chung Inflammatory biomarkers in severe asthma Curr Opin Pulm Med 18 2012 35 41
2. K.H. Yeh, M.E. Skowronski, A.J. Coreno, R.E. Seitz, K.D. Villalba, and H. Dickey-White et al. Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma J Asthma 48 2011 546 552
3. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
4. C. Alfarano, C.E. Andrade, K. Anthony, N. Bahroos, M. Bajec, and K. Bantoft et al. The Biomolecular Interaction Network Database and related tools 2005 update Nucleic Acids Res 33 2005 D418 D424
5. S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B. Trudeau, and R.L. Gibbs et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
6. A. ten Brinke, A.H. Zwinderman, P.J. Sterk, K.F. Rabe, and E.H. Bel "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids Am J Respir Crit Care Med 170 2004 601 605
7. P.E. Silkoff, P. McClean, M. Spino, L. Erlich, A.S. Slutsky, and N. Zamel Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients Chest 119 2001 1322 1328
8. R.A. Dweik, R.L. Sorkness, S. Wenzel, J. Hammel, D. Curran-Everett, and S.A. Comhair et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am J Respir Crit Care Med 181 2010 1033 1041
9. M. Yamamoto, Y. Tochino, K. Chibana, J.B. Trudeau, F. Holguin, and S.E. Wenzel Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation Clin Exp Allergy 42 2012 760 768